Atlanta biologicals INC:1109260 [18-051343]
Ended Purchase Order Awarded Last action
- Contract number
- 75N91018P00523
- Awardee
-
Atlanta Biologicals, Inc. UEI ULFTKRGFBBA5 Part of Bio-Techne Corporation
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $23,375
Award facts
- Contract value 100% obligated
- $23,375.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a purchase order to Atlanta Biologicals, Inc. for $23,375.10 on July 17, 2018, with an ultimate completion date of August 16, 2018. The order was issued on a firm fixed-price basis with no set-aside applied. Work is performed at Bethesda, Maryland. Atlanta Biologicals is a subsidiary of Bio-Techne Corporation, a provider of life sciences tools and bioactive reagents including proteins, antibodies, immunoassays, and small molecules for research and diagnostic applications.
Quick answers
Who was awarded contract 75N91018P00523?
75N91018P00523 was awarded to Atlanta Biologicals, Inc. by National Cancer Institute (National Institutes of Health) on July 17, 2018.
How much is contract 75N91018P00523 worth?
The government has obligated $23,375 on 75N91018P00523.
Was contract 75N91018P00523 competed?
The extent of competition for 75N91018P00523 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award